Early urinary tract infection after kidney transplantation: timing, stent association, extended-spectrum β-lactamase infections, and clinical outcomes in a large cohort.

Authors

Rehab Salah Fathy Nasr, Dieter Clemens Broering, Dalia Abdullah Ghalib Obeid, Reem Almaghrabi, Enas Mamdouh Mohamed Ali Hussein, Amir Nasser Teljabini, Manar Mohammed Saber Almadi, Tariq Zulfiqar Ali

Published in

Frontiers in transplantation. Volume 5. Pages 1902904. Epub Aug 11, 2026.

Abstract

Urinary tract infection (UTI) including extended-spectrum β-lactamase (ESBL)-producing organisms is a common early complication after kidney transplantation. Increasing prevalence of ESBL may adversely affect graft and patient outcomes. This study aimed to evaluate the incidence, timing, predictors, and outcomes of UTI, including ESBL infection, after kidney transplantation.
We retrospectively studied 1,804 adult kidney transplant recipients (2016-2024) at a tertiary center. UTIs were analyzed for incidence, timing, microbiology, and predictors using multivariable logistic regression. Outcomes included rejection, graft loss, and mortality. ESBL and non-ESBL UTIs were compared, and long-term outcomes assessed using Cox regression.
UTI occurred in 693 recipients (38.4%) within the first year post-transplant with 57.4% occurring within 30 days and 84.2% within 90 days. UTIs were more common during ureteric stent indwelling than after removal (64.3% vs. 35.7%). Independent predictors included female sex, older age, deceased donor transplantation, pre-transplant UTI, and post-transplant urological complications. ESBL UTI were identified in 47.9% of patients and were associated with earlier infection, higher recurrence rates and occurred more frequently during stent indwelling (69.0% vs. 60.1%, p = 0.015). UTI was associated with higher rejection, graft loss, and mortality (p ≤ 0.005). ESBL UTI further increased rejection and graft loss. In adjusted analyses, ESBL UTI independently associated with death-censored graft loss (aHR 2.10, p = 0.047) and mortality (aHR 2.17, p = 0.025).
UTIs are common early after kidney transplantation, particularly during ureteric stent indwelling. ESBL infections are independently associated with adverse graft outcomes and mortality, supporting targeted surveillance, antimicrobial stewardship, and ureteric stent management optimization.

PMID:
42643289
Bibliographic data and abstract were imported from PubMed on 26 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.